Owing to the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase as the downstream target of VPS34, the target may be a therapeutic strategy to treat tumor cells (Bago et al., 2014). The gene discussed is PIK3C3; the disease is neoplasm.